2007
DOI: 10.1507/endocrj.k07-126
|View full text |Cite
|
Sign up to set email alerts
|

Toxic Thyroid Adenoma Presenting as Hypokalemic Periodic Paralysis

Abstract: Abstract. Toxic thyroid adenoma presenting as hypokalemic periodic paralysis is extraordinarily rare. We describe a 26-year-old Japanese man who suffered from acute and painful muscle weakness of extremity in the morning. Physical examination showed a left anterior neck mass and laboratory tests revealed hypokalemia during his paralysis, and thyrotoxicosis. Neck sonogram showed a solitary nodule in the left lobe of the thyroid. Thyroid scintigraphy revealed a hot nodule of the tumor region with suppressed upta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 55 publications
1
8
0
Order By: Relevance
“…3 Thyroid hormone, b-adrenergic catecholamine and insulin can increase the pump activity in skeletal muscles, liver or kidneys. 5 This leads to a shift of potassium into the cells, manifested as low serum potassium, as seen in our patient, but without changing the total body potassium level. This may explain why weakness resolves when potassium returns to the extracellular space.…”
Section: Discussionsupporting
confidence: 60%
See 1 more Smart Citation
“…3 Thyroid hormone, b-adrenergic catecholamine and insulin can increase the pump activity in skeletal muscles, liver or kidneys. 5 This leads to a shift of potassium into the cells, manifested as low serum potassium, as seen in our patient, but without changing the total body potassium level. This may explain why weakness resolves when potassium returns to the extracellular space.…”
Section: Discussionsupporting
confidence: 60%
“…Moreover, mutations in the ionic channel genes such as CACNA1S, SCN4A and KCNE3 have been reported in the FHPP. 5 Definitive treatment of TPP consists in the management of thyrotoxicosis by medical therapy, surgery or radioactive iodine therapy. Treatment for an acute attack is potassium administration, but excessive doses of potassium can lead to hyperkalemia once potassium shifts to the extracellular space.…”
Section: Discussionmentioning
confidence: 99%
“…Graves' disease was distinguished from painless thyroiditis using Tbii and radioiodine thyroid scintigram [9,10], if necessary, based on the Japan Thyroid Association's guidelines for the diagnosis of graves' disease and painless thy-HDL-C decreased with aging. Because TT and OH (see Patients and Methods about the classification) may greatly influence these parameters, we also examined these relationships within eu and sH, and the similar tendencies were observed.…”
Section: Patientsmentioning
confidence: 99%
“…Patients with TPP have been reported with thyroiditis (3, 4), toxic adenoma (5), toxic nodular goiter (9), TSH-secreting pituitary adenoma (10, 11), ingestion of T4 or T3 (6, 12, 13), inadvertent iodine excess (14), subacute thyroiditis of de Quervain (15), amiodarone therapy (16), radiation thyroiditis with Graves' disease (17) and nutraceuticals containing triatricol (18). …”
Section: Discussionmentioning
confidence: 99%
“…The most common cause of TPP in thyrotoxicosis is Graves' disease, although TPP can occur with any form of thyrotoxicosis (1, 2). It is less commonly associated with thyroiditis (3, 4), toxic adenoma (5), T4 ingestion and iodine excess (6). However, very few cases such as this one have been reported as far as we know that thyrotoxic periodic paralysis associated with painless thyroiditis.…”
Section: Introductionmentioning
confidence: 99%